bluedoor data·H-1B Jobs API·bluedoor.sh ->

Home / Companies / Carmine Therapeutics Inc / Roles

Carmine Therapeutics Inc H-1B role rows

Row-level LCA role declarations for Carmine Therapeutics Inc, including title, SOC code, worksite, status, date fields, wage offer, prevailing wage, and source record evidence. Showing 11 returned rows using keyset pagination.

Summary

This view lists 11 H-1B LCA role records.

Offered wages among the returned rows range from $77,520 to $150,000.

Employers in the returned rows include Carmine Therapeutics, Inc..

LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.

RoleEmployerSOCStatus / visaDecisionWorksiteOffered wagePrevailing wageSource
Principal Scientist
I-202-22227-416221
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B1 Singapore
FY2022
2022-08-22
2022-09-06 to 2024-03-06
Cambridge, MA, 2140$150,000
year
$106,413sr_dol_oflc_lca_2022_q4_row_070314
Senior Scientist
I-200-22124-134338
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B
FY2022
2022-05-11
2022-10-01 to 2025-09-30
Cambridge, MA, 2140$110,000
year
$78,458sr_dol_oflc_lca_2022_q3_row_094598
Senior Research Associate
I-200-22124-134336
Carmine Therapeutics, Inc.19-1021.00
Biochemists and Biophysicists
Certified / H-1B
FY2022
2022-05-11
2022-10-01 to 2025-09-30
Cambridge, MA, 2140$77,520
year
$58,677sr_dol_oflc_lca_2022_q3_row_094891
Senior Scientist
I-202-21355-779300
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B1 Singapore
FY2022
2021-12-29
2022-01-01 to 2023-07-01
Cambridge, MA, 2139$110,000
year
$78,458sr_dol_oflc_lca_2022_q1_row_116782
Scientist II
I-202-21175-423999
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B1 Singapore
FY2021
2021-07-01
2021-09-02 to 2022-09-01
North Cambridge, MA, 2139$97,000
year
$81,682sr_dol_oflc_lca_2021_q4_row_000075
Principal Scientist
I-202-21152-358666
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B1 Singapore
FY2021
2021-06-08
2021-08-25 to 2022-08-24
North Cambridge, MA, 2139$127,440
year
$81,682sr_dol_oflc_lca_2021_q3_row_356114
Scientist II
I-200-21148-354169
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B
FY2021
2021-06-07
2021-10-01 to 2024-09-30
North Cambridge, MA, 2139$97,000
year
$81,682sr_dol_oflc_lca_2021_q3_row_352990
Scientist II
I-202-21148-354179
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Withdrawn / H-1B1 Singapore
FY2021
2021-06-01
2021-08-25 to 2022-08-24
North Cambridge, MA, 2139$127,440
year
$81,682sr_dol_oflc_lca_2021_q3_row_339671
Scientist II
I-202-20246-801265
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B1 Singapore
FY2020
2020-09-10
2020-10-01 to 2023-09-30
Cambridge, MA, 02139$100,000
year
$81,682sr_dol_oflc_lca_2020_q4_row_085043
Scientist II
I-202-20043-317232
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B1 Singapore
FY2020
2020-02-20
2020-03-01 to 2021-09-01
Cambridge, MA, 2142$95,000
year
$67,954sr_dol_oflc_lca_2020_q2_row_068502
Scientist II
I-202-20036-300906
Carmine Therapeutics, Inc.19-1029.02
Molecular and Cellular Biologists
Certified / H-1B1 Singapore
FY2020
2020-02-12
2020-02-24 to 2021-08-24
Cambridge, MA, 2142$80,000
year
$67,954sr_dol_oflc_lca_2020_q2_row_055124
End of returned pageReset

Frequently asked questions

What are the offered H-1B wages for Carmine Therapeutics Inc H-1B role rows?
Offered wages among the returned Carmine Therapeutics Inc H-1B role rows rows range from $77,520 to $150,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API

Rendered from the bluedoor H-1B Jobs API. Reproduce it:

GET https://api.bluedoor.sh/h1b-jobs/v1/roles?limit=50&company=carmine+therapeutics+incJSON